Every product on this site is supplied strictly for laboratory research use.
You must be 21 or older to enter.
Nothing sold here is intended for human or veterinary consumption, and none of it is
approved by the FDA to diagnose, treat, cure, or prevent any disease.
By entering, you confirm you are 21 or older, that you are a qualified buyer
purchasing for research purposes only, and that you agree to our
Terms & Release of Liability.
You must be 21 or older to access this site. Taking you back.
Tesamorelin is a stabilized GHRH analogue known for its potent growth-hormone–releasing activity and its influence on metabolic pathways. It is particularly well-studied for its ability to modulate IGF-1 and support lipid metabolism. This peptide has ideal research in these categories:
Muscle Growth & Performance
Metabolic Enhancement
Longevity & GH Support
Understanding This Peptide
This peptide is engineered to resist enzymatic breakdown, providing sustained GHRH receptor activity and predictable GH-pulse amplification. Tesamorelin is one of the most clinically supported peptides in the GH research category.
Mechanism of Action
Tesamorelin binds to GHRH receptors in the pituitary gland, stimulating GH release and downstream IGF-1 production. Its durability and potency allow researchers to explore strong metabolic and anabolic pathways.
Scientific Interest
Researchers prioritize Tesamorelin for its metabolic influence, including its documented effects on visceral fat metabolism and GH-axis signaling.
Research Focus & Clinical Landscape
Active areas of investigation include:
growth-hormone secretion
IGF-1 elevation
body-composition research
metabolism and fat oxidation
anabolic recovery
circadian rhythm and sleep pathways
Tesamorelin has extensive clinical research backing its activity profiles.
Quality, Craftsmanship & Purity
Manufactured at >98% purity and rigorously tested for potency and structural integrity, Tesamorelin is synthesized in GMP-compliant facilities.
Final Insight
Tesamorelin stands as one of the most potent and clinically validated GH-releasing peptides, offering remarkable consistency and scientific promise.
